Showing results (271-280 of 1,138) with videos related to
Sort By:
Pageof 114
Journal of Affective Disorders|March 31, 2019
Variation in the prevalence of depression and patterns of association, sociodemographic and lifestyle factors in community-dwelling older adults in six low- and middle-income countriesMojtaba Lotfaliany, Erin Hoare, Felice N Jacka, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 14, 2012
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitisLaura J Dixon, Michael Berk, Samjhana Thapaliya, et al.Hepatology (Baltimore, Md.)|January 29, 2008
The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicityZhengZheng Li, Michael Berk, Thomas M McIntyre, et al.Current Medical Research and Opinion|April 16, 2013
Baseline patient characteristics associated with placebo remission and their impact on remission with duloxetine and selected SSRI antidepressantsJ Craig Nelson, Qianyi Zhang, Katarina Kelin, et al.Journal of Affective Disorders|April 8, 2015
Instruments that prospectively predict bipolar disorder - A systematic reviewAswin Ratheesh, Michael Berk, Christopher G Davey, et al.Acta Neuropsychiatrica|March 19, 2016
Depression and pain: an overviewLana J Williams, Felice N Jacka, Julie A Pasco, et al.Bipolar Disorders|April 22, 2024
Prior psychiatric morbidity and differential psychopharmacological treatment patterns: Exploring the heterogeneity of bipolar disorder in a nationwide study of 9594 patientsAswin Ratheesh, Maria Speed, Estela Salagre, et al.Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|July 12, 2023
Person-centred growth-oriented language and care: Fundamental to successful mental health reformJames McLure, Tari Forrester-Bowling, Anna Peeters, et al.Expert Opinion on Therapeutic Targets|October 20, 2010
Oxidative pathways as a drug target for the treatment of autismKristi-Ann Villagonzalo, Seetal Dodd, Olivia Dean, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 27, 2012
Putative neuroprotective agents in neuropsychiatric disordersSeetal Dodd, Michael Maes, George Anderson, et al.Pageof 114